glycyrrhetinic acid and quercetin

glycyrrhetinic acid has been researched along with quercetin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Kirchmair, J; Laggner, C; Langer, T; Nashev, LG; Odermatt, A; Schuster, D; Wolber, G1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Awolade, P; Cele, N; Gummidi, L; Kerru, N; Oluwakemi, E; Singh, P1
Shen, P; Wang, W; Yu, B; Zhang, J; Zhu, Y1

Reviews

1 review(s) available for glycyrrhetinic acid and quercetin

ArticleYear
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
    European journal of medicinal chemistry, 2020, Feb-01, Volume: 187

    Topics: Dose-Response Relationship, Drug; Glucuronidase; Glycoproteins; Humans; Molecular Structure; Structure-Activity Relationship

2020

Other Studies

3 other study(ies) available for glycyrrhetinic acid and quercetin

ArticleYear
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: 17-Hydroxysteroid Dehydrogenases; Catalysis; Cell Line; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavonoids; Humans; Models, Chemical; Small Molecule Libraries

2008
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741.
    Bioorganic & medicinal chemistry, 2020, 06-01, Volume: 28, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Bacillus megaterium; Bacillus subtilis; Biotransformation; Dose-Response Relationship, Drug; Glycyrrhetinic Acid; Lipopolysaccharides; Mice; Molecular Conformation; Nitric Oxide; RAW 264.7 Cells; Stereoisomerism; Structure-Activity Relationship

2020